clinical trials

News

Transgene cervical cancer shot misses the mark in phase 2

Transgene's therapeutic vaccine for cervical and anogenital cancers has failed a phase 2 trial, but an efficacy signal warrants further study

News

GSK asthma hope depemokimab works in second indication

GSK's experimental IL-5 inhibitor depemokimab has shown its potential in a pair of phase 3 trials in patients with chronic rhinosinusitis with nasal polyps (CRSwNP).

News

Sage takes another hit as Alzheimer's drug is canned

Sage Therapeutics has said it will stop the development of dalzanemdor in Alzheimer's disease, a few months after pulling the plug on the drug in Parkinson's disease.

News

Setback for J&J's TAR-200 bladder cancer programme

A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme.

News

Scholar Rock preps filings after SMA antibody clears trial

Shares in Scholar Rock have gone into overdrive after the biotech reported positive phase 3 results with apitegromab in patients with spinal muscular atrophy (SMA), setting up regulatory fi

News

UK Health and Social Care Secretary Wes Streeting

NHS England to be given a bigger role in GP data sharing

UK Health Secretary Wes Streeting has announced plans to allow NHS England to share primary care data with scientific researchers, taking on some of the responsibility held by GPs.

Transgene cervical cancer shot misses the mark in phase 2

GSK asthma hope depemokimab works in second indication

Sage takes another hit as Alzheimer's drug is canned

Setback for J&J's TAR-200 bladder cancer programme

Scholar Rock preps filings after SMA antibody clears trial

NHS England to be given a bigger role in GP data sharing

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

clinical trials

Editor's Picks